These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 30095897)

  • 1. Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade.
    Savelieff MG; Nam G; Kang J; Lee HJ; Lee M; Lim MH
    Chem Rev; 2019 Jan; 119(2):1221-1322. PubMed ID: 30095897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological metals and metal-targeting compounds in major neurodegenerative diseases.
    Barnham KJ; Bush AI
    Chem Soc Rev; 2014 Oct; 43(19):6727-49. PubMed ID: 25099276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides.
    Singh K; Gupta JK; Kumar S; Soni U
    Curr Protein Pept Sci; 2024; 25(7):507-526. PubMed ID: 38561605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
    Di Matteo V; Esposito E
    Curr Drug Targets CNS Neurol Disord; 2003 Apr; 2(2):95-107. PubMed ID: 12769802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol: A Focus on Several Neurodegenerative Diseases.
    Tellone E; Galtieri A; Russo A; Giardina B; Ficarra S
    Oxid Med Cell Longev; 2015; 2015():392169. PubMed ID: 26180587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
    Hoogendijk WJ; Pool CW; Troost D; van Zwieten E; Swaab DF
    Brain; 1995 Feb; 118 ( Pt 1)():131-43. PubMed ID: 7894999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics of neurodegenerative diseases.
    Maimone D; Dominici R; Grimaldi LM
    Eur J Pharmacol; 2001 Feb; 413(1):11-29. PubMed ID: 11173059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders I: Parkinson's disease.
    Campos HC; da Rocha MD; Viegas FP; Nicastro PC; Fossaluzza PC; Fraga CA; Barreiro EJ; Viegas C
    CNS Neurol Disord Drug Targets; 2011 Mar; 10(2):239-50. PubMed ID: 20874702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
    Gaggelli E; Kozlowski H; Valensin D; Valensin G
    Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441
    [No Abstract]   [Full Text] [Related]  

  • 10. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.
    van Muiswinkel FL; Kuiperij HB
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):267-81. PubMed ID: 15975029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
    Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
    Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review.
    Bansal R; Singh R
    Med Res Rev; 2018 Jul; 38(4):1126-1158. PubMed ID: 28697282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental evidence for growth factor treatment and function in certain neurological disorders.
    Springer JE
    Exp Neurol; 1993 Nov; 124(1):2-4. PubMed ID: 8282074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription.
    Tatton WG; Chalmers-Redman RM; Ju WY; Wadia J; Tatton NA
    J Neural Transm Suppl; 1997; 49():245-68. PubMed ID: 9266433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography neuroimaging in neurodegenerative diseases: Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
    Barc K; Kuźma-Kozakiewicz M
    Neurol Neurochir Pol; 2019; 53(2):99-112. PubMed ID: 30855701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biomarkers of neurodegeneration.
    Höglund K; Salter H
    Expert Rev Mol Diagn; 2013 Nov; 13(8):845-61. PubMed ID: 24151849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases.
    Maher P
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical pharmacology and therapeutic aspects in certain degenerative neurological diseases].
    Maloteaux JM
    Bull Mem Acad R Med Belg; 1996; 151(10-11):429-32; discussion 432-4. PubMed ID: 9491620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metals and free radicals in neurodegeneration.
    Olanow CW; Arendash GW
    Curr Opin Neurol; 1994 Dec; 7(6):548-58. PubMed ID: 7866588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.